Therefore, in this study, we first combined scRNA-seq, proteomics, and bulk RNA-seq in order to investigate UNC5A's expression, prognosis, associated pathways or drugs, and clinical or immune relevance in gliomas. The gene discussed is UNC5A; the disease is central nervous system cancer.